Polygenic Risk Scores in Alzheimer’s Disease: A Cross-Scale View from Genes to Brain and Behavior Oct 29 2026
Cerebrospinal Fluid Over Plasma Links Analytes to Cognitive Decline in Older Adults at Risk for Alzheimer's Disease Sept 26 2026
Astrocyte reactivity identifies p-tau217-positive individuals at elevated risk of cognitive decline across the Alzheimer’s disease continuum Sept 21 2026
A scalable workflow using digital cognitive assessment and pTau217 for MCI detection - Sept 17 2026
APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers’s disease | Nature Genetics Sept 14 2026
Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies - The Lancet Neurology September 9 2026
Aberrant excitatory neuronal ERBB4 promotes Alzheimer’s disease pathology | Nature August 26 2026
Advancing a systems-level understanding of neurodegeneration: the BrightFocus Alzheimer’s disease research portfolio | Molecular Neurodegeneration | Springer Nature Link August 21 2026
A plasma‐based protein signature combining NPTXR, ACHE, and p‐tau217 predicts progression to symptomatic Alzheimer's disease August 14 2026
Regional astrocyte dysregulation and altered glymphatic‐related markers in Alzheimer's disease frontal cortex - August 14 2026
Proteomic signatures of protected APOE ε4 carriers reveal causal pathways associated with delayed Alzheimer's disease onset - Le Guen - 2026 - Alzheimer's & Dementia - Wiley Online Library August 13 2026
Vulnerability of locus coeruleus connections to aging and Alzheimer's disease - Zufiria‐Gerbolés - August 12 2026
Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers | Science Advances August 12 2026
Toward personalized medicine in AD/ADRD through genetic-exposome dementia risk assessments | npj Dementia August 12 2026
Glycation at the Gate: A Brain Endothelial Glycocalyx Model and Therapeutic Roadmap for Alzheimer's Disease August 10 2026
New human genome benchmark captures both parental copies with near-perfect accuracy August 10 2026
Plasma Biomarkers for Neocortical Tau Burden | Radiology | JAMA Neurology | JAMA Network (p-tau217, NPTXR, GDNF, KLK6, IL-13, Aβ40, and SFRP1) August 10 2026
Frontiers | Circulating neuron-derived cfDNA for blood-based detection of Alzheimer’s and other neurodegenerative conditions Aug 5 2026
Evaluating digital cognitive tests for clinical use in Alzheimer's disease: A novel framework and scoping review - Hampel - 2026 - Alzheimer's & Dementia - Wiley Online Library July 31 2026
Cytoplasmic DNA Sensing Links LINE-1 Expression to Neuronal Senescence in Alzheimer's Disease | bioRxiv July 28 2026
Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS | Nature Medicine July 27 2026
Mitochondrial accumulation and lysosomal dysfunction result in mitochondrial plaques in Alzheimer's disease | Nature Neuroscience July 26 2026
Cross‐ancestry polygenic risk scores enhance Alzheimer's disease risk prediction in multiethnic cohorts - Okorie - 2026 - Alzheimer's & Dementia - Wiley Online Library July 26 2026
Epigenetic and 3D genome reprogramming during the aging of the human hippocampus | Science July 23 2026
APOE4 disrupts the central dogma by arresting neuronal proteome dynamics | bioRxiv July 22 2026
Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging | Science July 16 2026
Cell-type signatures of Alzheimer's disease shared across population groups | Nature July 15 2026
Predicting Risk of Cognitive Impairment with Alzheimer's Disease Blood Biomarkers July 14 2026
CIT-Lasso: a scalable approach beyond guilty by association for identifying causal variants from genome-wide summary statistics July 3 2026
Multiregional single-cell profiling reveals shared and specialized cellular vulnerability in Alzheimer's disease | bioRxiv July 2 2026
Alzheimer's disease proteome-wide association study implicates adaptive immunity and identifies risk genes LILRB1 and SIRPA | Science Translational Medicine July 1 2026
Blood-based circular RNAs for early diagnosis of Alzheimer’s disease | Nature Medicine July 1 2026
SECmeres outperform extracellular vesicles as potential blood RNA biomarkers for Alzheimer's disease | Nature Communications June 22 2026
A new hope: locus coeruleus-norepinephrine system at the nexus of neuropsychiatric symptoms | Molecular Psychiatry June 22 2026
APOE4 risk‐modifying genes and drug targets in Alzheimer's disease through cell‐type‐specific genomic analyses June 22 2026
Unraveling Aberrant Metabolic Patterns in Alzheimer's Disease Subtypes: From Perturbed Metabolic Pathways to Candidate Drug Targets | Molecular Neurobiology | Springer Nature Link June 18 2026
Discovery Driven plasma proteomics Identifies a Multi-Protein Signature for Amyloid PET Positivity: A Machine Learning Analysis of the Bio-Hermes Cohort June 18 2026
A blood test for dementia may tell you if you have more than one type June 16 2026
Plasma proteomic signatures of cellular aging predict human disease | Nature Medicine June 14 2026
GWAS on short tandem repeats identifies genetic mechanisms in Alzheimer's disease | Nature Communications June 4 2026
Primary prevention of Alzheimer disease in dominantly inherited Alzheimer network: a platform trial design | npj Dementia June 1 2026
The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions May 18 2026
Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures Cell. 189(10): 3124–3143.e15. doi:10.1016/j.cell.2026.02.026 May 14 2026
Alzheimer's disease - ScienceDirect May 30 2026
Neuroproteasomes regulate endogenous tau paired helical filament formation in an APOE genotype- and age-dependent manner | Nature Neuroscience May 29 2026
Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer's disease pathology | Nature Aging May 14 2026
Linking the exposome to the brain–behaviour phenotype | Nature Reviews Neuroscience May 14 2026
Cell-type-specific APOE4 cascade across the Alzheimer's disease continuum: Neuron May 14 2026
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals with Subjective Cognitive Decline. Neurology. June 9 2026. published online May 14 2026
BcnPit - Ace Alzheimer Center Barcelona May 13-15 2026
Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease | Nature Aging May 15 2026 Preprinted Aug 2025
Association of Rare APOE Missense Variants R189C and W276C With Risk of Alzheimer Disease | medRxiv May 12 2026
Early syndecan-4 upregulation predicts cognitive and pathological trajectories in Alzheimer disease | Alzheimer's Research & Therapy | Springer Nature Link May 7 2026
GPND‐AI NULISA: A 15‐Protein AI classifier for diagnosis and co‐pathology profiling across neurodegenerative diseases - Xu - 2026 - Alzheimer's & Dementia - Wiley Online Library April 28 2026
https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2026.1748524/full April 21 2026
Neurexins, Ephrin receptors, and N-cadherin signaling as emerging mechanisms in synaptic dysfunction and neurodegenerative diseases April 17 2026
Early peripheral immune signaling precedes tau elevation and blood–brain barrier disruption in Alzheimer's disease | bioRxiv April 4 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseases | Wu Tsai Neurosciences Institute March 31 2026
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia | Nature Medicine March 31 2026
Prevention Research Consortium obtains IRB approval for a Predict Predementia Longitudinal observation study of ApoE4 Carriers. March 26 2026
Population-scale burden analysis of rare damaging coding variants identifies novel risk genes for Alzheimer’s disease and Parkinson’s disease | medRxiv March 4 2026
Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks | Nature Medicine Feb 19 2026
Identification of plasma inflammatory biomarkers for Alzheimer's disease reveals IFN-γ as a regulator of ACSL1-mediated microglia phenotype Feb 15 2026
APOE‐stratified Proteomic and Metabolomic Analysis Reveals Mitochondrial Dysfunction Inflammation and Lipid Dysregulation in Alzheimer's Disease - Li - 2026 - Advanced Science - Wiley Online Library Feb 5 2026
Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognition | Brain | Oxford Academic Feb 25 2026
Cures Alzheimer's Fund Grants Award for Proteogenomic Model that predicts Late onset Alzheimer's Disease. Feb 2026
Large‐scale proteomics analysis of Alzheimer's Disease plasma blood reveals sex and APOE specific signatures - PMC Jan 12 2026
Integrating large-scale serum metabolomics and APOE ε4 genotype status for the non-invasive detection of Alzheimer's disease in the ADNI cohort - PubMed Jan 2026
Thomassen JQ, Leonard H, Ulms B, et al. APOE stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimer's disease. medRxiv. Preprint Published online December 19, 2025 December 19 2025
Staging Alzheimer's disease through amyloid and tau PET | Brain | Oxford Academic Sept 25 2025
The China Alzheimer Report 2025 - PubMed August 7 2025
Protein-based Diagnosis and Analysis of Co-pathologies Across Neurodegenerative Diseases: Large-Scale AI-Boosted CSF and Plasma Classification July 10 2025
Predicting brain health in community-dwelling elderly populations by integrating Gaussian mixture model and plasma biomarkers https://journals.sagepub.com/doi/10.1177/25424823251331110 June 24 2025
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's disease | Nature Medicine March 31 2025
The Dementia SomaSignal Test (dSST): A plasma proteomic predictor of 20-year dementia risk - PubMed Feb 12 2025
Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer’s disease | Scientific Reports April 23 2025
Non-coding RNAs in the pathogenesis of Alzheimer’s disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation | Molecular Biology Reports | Springer Nature Link January 31 2025
Polygenic burden of short tandem repeat expansions promotes risk for Alzheimer's disease - PubMed Jan 2025
Identifying proteomic prognostic markers for Alzheimer's disease with survival machine learning: The Framingham Heart Study - PMC Jan 21 2025
Noncoding RNAs in Alzheimer’s Disease: Overview of Functional and Therapeutic Significance | Bentham Science April 9 2024
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Feb 27 2024
Plasma proteomic profiles predict future dementia in healthy adults | Nature Aging Feb 12 2024 (summary and comments - nature_aging_24b.pdf)
Alzheimer's disease‐associated P460L variant of EphA1 dysregulates receptor activity and blood‐brain barrier function - PMC January 7 2024
Road map for clinicians to develop and evaluate AI predictive models to inform clinical decision-making - PMC August 2023
Aging gene signature of IL-7 receptor alpha low effector memory CD8+ T cells is associated with neurocognitive functioning in Alzheimer's disease April 4 2023
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's disease | GeroScience | Springer Nature Link May 19 2022
Immune system and blood-brain barrier-wide biomarker analyses provide causal evidence for autoimmunity in dementia February 16 2021
Compromised Behavior and Gamma Power During Working Memory in Cognitively Healthy Individuals With Abnormal CSF Amyloid/Tau Oct 14 2020
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease Aug 28 2018
Frontiers | Circular RNAs: Novel Regulators of Neuronal Development August 25 2016
Development of Screening Guidelines and Clinical Criteria for Predementia Alzheimer's Disease: The DESCRIPA Study - PMC June 2 2008